Brainstorm Cell Therapeutics
Why Robinhood?
You can watch BCLI and buy or sell other stocks, ETFs, and their options commission-free!About BCLI
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function.
BCLI Key Statistics
Stock Snapshot
As of today, Brainstorm Cell Therapeutics(BCLI) shares are valued at $0.86. The company's market cap stands at 69.71M, with a P/E ratio of -15.25.
As of 2026-06-20, Brainstorm Cell Therapeutics(BCLI) stock has fluctuated between $0.80 and $0.87. The current price stands at $0.86, placing the stock +8.7% above today's low and -0.9% off the high.
The Brainstorm Cell Therapeutics(BCLI)'s current trading volume is 1.06K, compared to an average daily volume of 385.89K.
In the last year, Brainstorm Cell Therapeutics(BCLI) shares hit a 52-week high of $0.87 and a 52-week low of $0.13.
In the last year, Brainstorm Cell Therapeutics(BCLI) shares hit a 52-week high of $0.87 and a 52-week low of $0.13.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.